China's TEDA International Cardiovascular Hospital & China Academy of Launch Vehicle Technology developed the HeartCon artificial heart, saving 190 severe heart failure patients using aerospace technology.

China's TEDA International Cardiovascular Hospital & China Academy of Launch Vehicle Technology developed the HeartCon artificial heart, saving 190 severe heart failure patients. Powered by aerospace technology, this cheaper alternative to imported products functions as a rocket's servomechanism & extends lives where human organ transplants are limited. Since gaining market approval in 2022, HeartCon II is being tested.

August 17, 2024
4 Articles